Atlas Trials

Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma

Clinical trial NCT01476839 · COMPLETED

Trial details

NCT number
NCT01476839
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Adult Hodgkin Lymphoma
Start date
2012-11-09
Primary completion
2021-07-24
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.